サマリー

ヒトパピローマウイルス（HPV）治療薬の世界市場 2023-2027
Technavioは、ヒトパピローマウイルス（HPV）治療薬市場を監視しており、2022年から2027年の間に9億5330万ドル、予測期間中のCAGRは5.15%で加速して成長すると予測しています。当レポートでは、ヒトパピローマウイルス（HPV）治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新トレンドやドライバー、市場環境全体に関する最新の分析を提供しています。市場は、ワクチンの登場、HPV用経口ワクチンの開発、強力な疾患進行によって牽引されています。
Technavioのヒトパピローマウイルス（HPV）治療薬市場は以下のように区分されます：
投与経路別
- 非経口
- トピカル
表示による
- 子宮頸がん
- 肛門がん
- 外陰・膣がん
- その他
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間におけるヒトパピローマウイルス（HPV）治療薬市場の成長を促す主な理由の一つとして、起立性低血圧治療薬の新薬の研究開発を挙げています。また、治療における併用療法の使用や、フルドロコルチゾンのオフラベルファーストライン薬物療法としての採用は、市場の大きな需要につながるでしょう。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、ヒトパピローマウイルス（HPV）治療薬市場について、以下の分野を取り上げています：
- ヒトパピローマウイルス（HPV）治療薬市場のサイジング
- ヒトパピローマウイルス（HPV）治療薬市場予測
- ヒトパピローマウイルス（HPV）治療薬市場産業分析
Technavioの強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、2A Pharma ApS、AbbVie Inc、Bavarian Nordic AS、BioVaxys Technology Corp、F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc、ISA Pharmaceuticals BV、 Serum Institute of India Pvt.Ltd., Walvax Biotechnology Co.Ltd.、Xiamen Innovax Biotech Co.Ltd.、Merck and Co.Inc.、Bausch Health Co.Inc.、Inovio Pharmaceuticals Inc.などです。また、ヒトパピローマウイルス（HPV）治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/human-papillomavirus-hpv-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021 ($ million)
o 4.2 route of administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - route of administration Segment 2017 - 2021 ($ million)
o 4.3 Indication Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Parenteral - Market size and forecast 2022-2027
o Exhibit 34: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
o 6.4 Topical - Market size and forecast 2022-2027
o Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Indication
o 7.1 Market segments
o Exhibit 44: Chart on Indication - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Indication - Market share 2022-2027 (%)
o 7.2 Comparison by Indication
o Exhibit 46: Chart on Comparison by Indication
o Exhibit 47: Data Table on Comparison by Indication
o 7.3 Cervical cancer - Market size and forecast 2022-2027
o Exhibit 48: Chart on Cervical cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Cervical cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Cervical cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Cervical cancer - Year-over-year growth 2022-2027 (%)
o 7.4 Anal cancer - Market size and forecast 2022-2027
o Exhibit 52: Chart on Anal cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Anal cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Anal cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Anal cancer - Year-over-year growth 2022-2027 (%)
o 7.5 Vulvar and vaginal cancer - Market size and forecast 2022-2027
o Exhibit 56: Chart on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Indication
o Exhibit 64: Market opportunity by Indication ($ million)
o Exhibit 65: Data Table on Market opportunity by Indication ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Brazil - Market size and forecast 2022-2027
o Exhibit 103: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Brazil - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 2A Pharma ApS
o Exhibit 115: 2A Pharma ApS - Overview
o Exhibit 116: 2A Pharma ApS - Product / Service
o Exhibit 117: 2A Pharma ApS - Key offerings
o 12.4 AbbVie Inc.
o Exhibit 118: AbbVie Inc. - Overview
o Exhibit 119: AbbVie Inc. - Product / Service
o Exhibit 120: AbbVie Inc. - Key news
o Exhibit 121: AbbVie Inc. - Key offerings
o 12.5 Bausch Health Co. Inc.
o Exhibit 122: Bausch Health Co. Inc. - Overview
o Exhibit 123: Bausch Health Co. Inc. - Business segments
o Exhibit 124: Bausch Health Co. Inc. - Key news
o Exhibit 125: Bausch Health Co. Inc. - Key offerings
o Exhibit 126: Bausch Health Co. Inc. - Segment focus
o 12.6 Bavarian Nordic AS
o Exhibit 127: Bavarian Nordic AS - Overview
o Exhibit 128: Bavarian Nordic AS - Product / Service
o Exhibit 129: Bavarian Nordic AS - Key offerings
o 12.7 BioVaxys Technology Corp.
o Exhibit 130: BioVaxys Technology Corp. - Overview
o Exhibit 131: BioVaxys Technology Corp. - Product / Service
o Exhibit 132: BioVaxys Technology Corp. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 138: GlaxoSmithKline Plc - Overview
o Exhibit 139: GlaxoSmithKline Plc - Business segments
o Exhibit 140: GlaxoSmithKline Plc - Key offerings
o Exhibit 141: GlaxoSmithKline Plc - Segment focus
o 12.10 Inovio Pharmaceuticals Inc.
o Exhibit 142: Inovio Pharmaceuticals Inc. - Overview
o Exhibit 143: Inovio Pharmaceuticals Inc. - Product / Service
o Exhibit 144: Inovio Pharmaceuticals Inc. - Key news
o Exhibit 145: Inovio Pharmaceuticals Inc. - Key offerings
o 12.11 ISA Pharmaceuticals BV
o Exhibit 146: ISA Pharmaceuticals BV - Overview
o Exhibit 147: ISA Pharmaceuticals BV - Product / Service
o Exhibit 148: ISA Pharmaceuticals BV - Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 149: Merck and Co. Inc. - Overview
o Exhibit 150: Merck and Co. Inc. - Business segments
o Exhibit 151: Merck and Co. Inc. - Key news
o Exhibit 152: Merck and Co. Inc. - Key offerings
o Exhibit 153: Merck and Co. Inc. - Segment focus
o 12.13 Serum Institute of India Pvt. Ltd.
o Exhibit 154: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 155: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 156: Serum Institute of India Pvt. Ltd. - Key offerings
o 12.14 Walvax Biotechnology Co. Ltd.
o Exhibit 157: Walvax Biotechnology Co. Ltd. - Overview
o Exhibit 158: Walvax Biotechnology Co. Ltd. - Product / Service
o Exhibit 159: Walvax Biotechnology Co. Ltd. - Key offerings
o 12.15 Xiamen Innovax Biotech Co. Ltd.
o Exhibit 160: Xiamen Innovax Biotech Co. Ltd. - Overview
o Exhibit 161: Xiamen Innovax Biotech Co. Ltd. - Product / Service
o Exhibit 162: Xiamen Innovax Biotech Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - route of administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Indication - Market share 2022-2027 (%)
Exhibits45: Data Table on Indication - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Indication
Exhibits47: Data Table on Comparison by Indication
Exhibits48: Chart on Cervical cancer - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Cervical cancer - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Cervical cancer - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Cervical cancer - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Anal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Anal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Anal cancer - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Anal cancer - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Indication ($ million)
Exhibits65: Data Table on Market opportunity by Indication ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Brazil - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: 2A Pharma ApS - Overview
Exhibits116: 2A Pharma ApS - Product / Service
Exhibits117: 2A Pharma ApS - Key offerings
Exhibits118: AbbVie Inc. - Overview
Exhibits119: AbbVie Inc. - Product / Service
Exhibits120: AbbVie Inc. - Key news
Exhibits121: AbbVie Inc. - Key offerings
Exhibits122: Bausch Health Co. Inc. - Overview
Exhibits123: Bausch Health Co. Inc. - Business segments
Exhibits124: Bausch Health Co. Inc. - Key news
Exhibits125: Bausch Health Co. Inc. - Key offerings
Exhibits126: Bausch Health Co. Inc. - Segment focus
Exhibits127: Bavarian Nordic AS - Overview
Exhibits128: Bavarian Nordic AS - Product / Service
Exhibits129: Bavarian Nordic AS - Key offerings
Exhibits130: BioVaxys Technology Corp. - Overview
Exhibits131: BioVaxys Technology Corp. - Product / Service
Exhibits132: BioVaxys Technology Corp. - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Overview
Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits135: F. Hoffmann La Roche Ltd. - Key news
Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key offerings
Exhibits141: GlaxoSmithKline Plc - Segment focus
Exhibits142: Inovio Pharmaceuticals Inc. - Overview
Exhibits143: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits144: Inovio Pharmaceuticals Inc. - Key news
Exhibits145: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits146: ISA Pharmaceuticals BV - Overview
Exhibits147: ISA Pharmaceuticals BV - Product / Service
Exhibits148: ISA Pharmaceuticals BV - Key offerings
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Serum Institute of India Pvt. Ltd. - Overview
Exhibits155: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits156: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits157: Walvax Biotechnology Co. Ltd. - Overview
Exhibits158: Walvax Biotechnology Co. Ltd. - Product / Service
Exhibits159: Walvax Biotechnology Co. Ltd. - Key offerings
Exhibits160: Xiamen Innovax Biotech Co. Ltd. - Overview
Exhibits161: Xiamen Innovax Biotech Co. Ltd. - Product / Service
Exhibits162: Xiamen Innovax Biotech Co. Ltd. - Key offerings
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations